Telix Pharmaceuticals (TLX) Other Gross PP&E Adjustments (2023 - 2024)

Telix Pharmaceuticals (TLX) has disclosed Other Gross PP&E Adjustments for 2 consecutive years, with $31.4 million as the latest value for Q4 2024.

  • Quarterly Other Gross PP&E Adjustments rose 91.98% to $31.4 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $31.4 million through Dec 2024, up 91.98% year-over-year, with the annual reading at $31.4 million for FY2024, 91.98% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2024 was $31.4 million at Telix Pharmaceuticals, up from $16.4 million in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $31.4 million in Q4 2024, with the low at $16.4 million in Q4 2023.